BCL2L2 抗体
Quick Overview for BCL2L2 抗体 (ABIN6936493)
抗原
See all BCL2L2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- BCLW promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
-
交叉反应 (详细)
- Human.
-
纯化方法
- 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
-
免疫原
- Recombinant human full-length BCL2L2 protein
-
亚型
- IgG1 kappa
-
-
-
-
应用备注
-
Known_Application: ELISA (For coating, order antibody without BSA), ,Western Blot (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.
Positive_Control: PC-3, HEK293, HePG2, MCF-7 or U87 cells.
-
限制
- 仅限研究用
-
-
-
浓度
- 1.0 mg/mL
-
缓冲液
- Prepared in 10 mM PBS, WITHOUT BSA and Azide.
-
储存液
- Azide free
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
-
有效期
- 24 months
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
别名
- BCL2L2
-
背景
-
BCL-W, BCL2-L-2, BCLW, KIAA0271, PPP1R51,BCL2-like 2
Cellular localisation: Ubiquitous cytoplasmic expression. -
分子量
- 22-30kDa
-
基因ID
- 599, 410026
-
UniProt
- Q92843
抗原
-